<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03234023</url>
  </required_header>
  <id_info>
    <org_study_id>2017/101</org_study_id>
    <secondary_id>SPRING</secondary_id>
    <nct_id>NCT03234023</nct_id>
  </id_info>
  <brief_title>Secondary PRevention in Cardiovascular Disease by a Nursing Guide Program (SPRING)</brief_title>
  <acronym>SPRING</acronym>
  <official_title>Secondary PRevention in Cardiovascular Diseaseby a Nursing Guide Program. SPRING Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital A Coruña</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital A Coruña</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      DESIGN: Controlled clinical trial with single randomization, unmasked, open and multicentric.

      CENTERS: University Hospital of A Coruña and University Hospital of Ferrol CONDITION TO
      STUDY: Acute Coronary Syndrome (ACS). INTERVENTION:monitored not supervised. MAIN OBJECTIVE:
      To determine the incidence of major adverse cardiac events, MACE (total mortality, new ACS,
      coronary revascularization, all-cause hospitalization) during the one-year period after
      hospitalization for ACS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>major adverse cardiac events</measure>
    <time_frame>2 years</time_frame>
    <description>(total mortality, new ACS, coronary revascularization, hospitalization for any cause)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">484</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Nutrition</condition>
  <condition>Physical Activity</condition>
  <arm_group>
    <arm_group_label>INTERVENTION GROUP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The participants of this group will follow recommendations of food, physical exercise, control of consumption of drugs and consumption of alcohol and tobacco.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CONTROL GROUP</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The participants of this group are submitted to the standard intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>INTERVENTION GROUP</intervention_name>
    <description>Offer recommendations of healthy living habits and control of pharmacy administration</description>
    <arm_group_label>INTERVENTION GROUP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who have suffered an ACS in the health area of A Coruña from the
             beginning of the study inclusion period until reaching the fixed sample size.

          -  Ages between 18 and 75 years.

          -  Patients with ability to read and understand the participation sheet in the study.

          -  Patients signing informed consent to participate in the study.

          -  Patients living in the health care area of HUAC.

          -  Patients who possess and know how to operate with a smart mobile phone (Smartphone
             type).

        Exclusion Criteria:

          -  Patients who are dependent for the Basic Activities of Daily Living (BADL) or who
             suffer from severe cognitive impairment (which makes reliable anamnesis impossible).

          -  Patients with a Left Ventricular Ejection Fraction (LVEF) less than or equal to 30%.

          -  Patients with a NYHA III / IV score and / or the Canadian Cardiovascular Association
             (CCS) scale of IV.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmen Neri Fernández Pombo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital A Coruña</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guillermo Aldama, MD</last_name>
    <phone>+34981178031</phone>
    <phone_ext>201314</phone_ext>
    <email>guillermo.aldama.lopez@sergas.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>José Manuel Vazquez Rodriguez, MD</last_name>
    <phone>+34981178031</phone>
    <phone_ext>291314</phone_ext>
    <email>jose.manuel.vazquez.rodriguez@sergas.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Ferrol</name>
      <address>
        <city>Ferrol</city>
        <state>A Coruña</state>
        <zip>15405</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manuel López, MD</last_name>
      <phone>0034 981334000</phone>
      <email>manuel.lopez.perez@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Marta Lorenzo</last_name>
      <phone>0034665833511</phone>
      <email>mlcarpente@live.com</email>
    </contact_backup>
    <investigator>
      <last_name>Manuel López Pérez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital of A Coruña</name>
      <address>
        <city>A Coruña</city>
        <state>Galicia</state>
        <zip>15006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmen Neri Fernández Pombo, PhD</last_name>
      <phone>+34981178031</phone>
      <phone_ext>291314</phone_ext>
      <email>carmen.neri.fernandez.pombo@sergas.es</email>
    </contact>
    <contact_backup>
      <last_name>Guillermo Aldama, MD</last_name>
      <phone>+34981178031</phone>
      <phone_ext>291314</phone_ext>
      <email>guillermo.aldama.lopez@sergas.es</email>
    </contact_backup>
    <investigator>
      <last_name>Guillermo Aldama López, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José Manuel Vázquez Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>July 25, 2017</study_first_submitted>
  <study_first_submitted_qc>July 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 31, 2017</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital A Coruña</investigator_affiliation>
    <investigator_full_name>CARMEN NERI FERNANDEZ POMBO</investigator_full_name>
    <investigator_title>Research Nurse.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data of the participants can not be used by other researchers</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

